| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |